Cleared Special

K200917 - Azurion R2.1 (FDA 510(k) Clearance)

May 2020
Decision
25d
Days
Class 2
Risk

K200917 is an FDA 510(k) clearance for the Azurion R2.1. This device is classified as a Interventional Fluoroscopic X-ray System (Class II - Special Controls, product code OWB).

Submitted by Philips Medical Systems Nederland B.V. (Best Noord-Brabant, NL). The FDA issued a Cleared decision on May 1, 2020, 25 days after receiving the submission on April 6, 2020.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.1650. Interventional Fluoroscopy.

Submission Details

510(k) Number K200917 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 2020
Decision Date May 01, 2020
Days to Decision 25 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code OWB — Interventional Fluoroscopic X-ray System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy

Similar Devices — OWB Interventional Fluoroscopic X-ray System

All 37
Alphenix, INFX-8000V/B, INFX-8000V/S, V9.6 with aEvolve Imaging (FOV Extension)
K253584 · Canon Medical Systems Corporation · Mar 2026
Allia Moveo
K251199 · GE Medical Systems SCS · Dec 2025
Cios Select
K250241 · Siemens Medical Solutions USA, Inc. · Nov 2025
Alphenix, INFX-8000V/B, INFX-8000V/S, V9.6 with aEvolve Imaging
K251602 · Canon Medical Systems Corporation · Oct 2025
Cios Spin
K251523 · Siemens Medical Solutions USA, Inc. · Jul 2025
Vascular Navigation PAD 2.0
K243432 · Brainlab AG · Jul 2025